Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Promis Neurosciences (PMN) had Non-Operating Income/Expense of $0.54M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-11.73M |
|
-- |
|
-- |
|
$12.27M |
|
$-12.27M |
|
|
Non-Operating Income/Expense |
$0.54M |
$-11.73M |
|
$-11.73M |
|
$-11.73M |
|
$-11.73M |
|
$-11.73M |
|
$-11.73M |
|
$-12.27M |
|
$-12.27M |
|
9.14M |
|
9.14M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$56.69M |
|
-- |
|
-- |
|
$56.69M |
|
$7.22M |
|
-- |
|
$0.08M |
|
$7.29M |
|
$49.40M |
|
$49.40M |
|
$49.40M |
|
8.97M |
|
| Cash Flow Statement Financials | |
$-22.77M |
|
-- |
|
$70.08M |
|
$6.12M |
|
$53.43M |
|
$47.31M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.74% |
|
-23.74% |
|
-20.69% |
|
-23.74% |
|
$5.51 |
|
$-2.49 |
|
$-2.49 |
|